Publications by authors named "Beth C Jorgenson"

Claim this Profile
E
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Jay H Traverse, Timothy D Henry, Stephen G Ellis, Carl J Pepine, James T Willerson, Beth C Jorgenson

JAMA· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oversight and management of a cell therapy clinical trial network: experience and lessons learned.
Lemuel A Moyé, Shelly L Sayre, Lynette Westbrook, Beth C Jorgenson, Eileen Handberg

Contemp Clin Trials· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, Stephen G Ellis, Carl J Pepine, Beth C Jorgenson

Tex Heart Inst J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, Stephen G Ellis, Carl J Pepine, Beth C Jorgenson

Am Heart J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis